Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy

Kyung Eun Ha1, Kang-Un Choi2, Hee-Jung Lee1

  • 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

ESC Heart Failure
|July 24, 2023
PubMed

Insights

Septal reduction therapy improved left atrial function in hypertrophic cardiomyopathy patients by reducing volume and restoring mechanical function. However, left ventricular mechanical function deteriorated post-surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Left atrial (LA) and left ventricular (LV) mechanical function are prognostic in hypertrophic cardiomyopathy (HCM).
  • Obstructive HCM causes significant symptoms and requires effective treatment.

Purpose of the Study:

  • To evaluate the impact of septal reduction therapy on myocardial mechanical function in patients with symptomatic obstructive HCM.
  • To assess changes in LA and LV function after septal myectomy.

Main Methods:

  • Retrospective analysis of 44 patients with obstructive HCM undergoing septal myectomy.
  • Echocardiography and speckle-tracking assessed LA strain and LV global longitudinal strain before and 1 year post-surgery.

Main Results:

  • Septal myectomy significantly reduced LA volume index (P=0.001).
  • LA strain improved post-surgery (P=0.004), indicating restored mechanical function.
  • LV ejection fraction decreased (P<0.001) and LV global longitudinal strain deteriorated (P=0.033).

Conclusions:

  • Surgical septal reduction therapy relieved LV outflow tract obstruction, reducing LA volume and restoring LA mechanical function.
  • Despite improved LA function, LV mechanical dysfunction worsened after septal myectomy in obstructive HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
18